Source: Eur Respir J 2011; 37: 221-222



Rating:

Share or cite this content

Citations should be made in the following way:
Zellweger A., Zellweger J-P.. Influence of pre-analytic conditions on the rate of indeterminate T-SPOT®.TB tests. Eur Respir J 2011; 37: 221-222

Member's Comments

No comment yet.

Related content which might interest you: Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017 Year: 2017 Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients? Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020 LATE-BREAKING ABSTRACT: Agreement between Quantiferon-TB-Gold In Tube, T-SPOT.TB and tuberculin skin testing for diagnosing latent tuberculosis infection in a contact tracing study Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Discordance QuantiFERON-TB Gold in-tube and tuberculin skin test: Latent tuberculosis infection or immunological memory? Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 133s Year: 2007 Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 Comparation of QFT-GIT test and tubeculine skin test in patients with sarcoidosis Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008